Does Sjögren's syndrome cause constipation?

Does Sjögren's Syndrome Cause Constipation?

Yes, Sjögren's syndrome can cause constipation, with more than half of patients (54%) experiencing this symptom as part of the disease's gastrointestinal manifestations 1.

Evidence for Gastrointestinal Involvement

While Sjögren's syndrome is classically known for causing dry eyes and dry mouth through exocrine gland dysfunction, gastrointestinal symptoms are remarkably common but often overlooked. A pilot study specifically examining abdominal symptoms in primary Sjögren's syndrome found that 95% of patients experienced some form of gastrointestinal complaint, with constipation affecting 54% of the cohort 1. This represents a substantial burden that is frequently underrecognized in clinical practice.

The same study revealed that patients experienced a median global symptom score of 7.5 ± 5.5 points out of 30, indicating moderate symptom severity. Beyond constipation, other common complaints included:

• Abdominal tension (68%)
• Abdominal discomfort (58%)
• Upper abdominal pain (54%)

Mechanisms and Clinical Context

The pathophysiological mechanisms underlying constipation in Sjögren's syndrome remain incompletely understood 1. However, several factors likely contribute:

Autonomic dysfunction is well-documented in Sjögren's syndrome, particularly in patients with hypermobile Ehlers-Danlos syndrome overlap, where autonomic dysregulation can affect gastrointestinal motility 2. The disease can affect both smooth muscle and neural control of the GI tract.

Secretory dysfunction extends beyond salivary and lacrimal glands. The same autoimmune process affecting exocrine glands throughout the body may impair intestinal secretions necessary for normal bowel function 3, 4.

Systemic disease activity correlates with gastrointestinal symptoms. The study found that higher EULAR Sjögren Syndrome Patient Reported Index (ESSPRI) scores—which measure dryness, fatigue, and pain—were positively correlated with more severe abdominal symptoms (p < 0.01) 1.

Clinical Recognition and Assessment

Constipation should be actively identified and managed in Sjögren's patients, as gastrointestinal manifestations are not routinely assessed despite their frequency 5. The EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) notably excludes the gastrointestinal tract from its 12 domains, which may contribute to underdiagnosis 5.

When evaluating constipation in Sjögren's patients, consider:

• SSA seronegativity was associated with higher gastrointestinal symptom scores in multivariate analysis 1
• Gastroparesis may coexist and was significantly associated with higher symptom burden 1
• Systemic disease activity, particularly general and central nervous system involvement, correlates with worse GI symptoms 1

Management Approach

While there are currently no specific therapeutic recommendations for Sjögren's-related constipation due to limited understanding of underlying mechanisms 1, a rational approach includes:

First-line management should follow standard constipation algorithms:

• Increase fluid intake (though challenging given sicca symptoms)
• Increase dietary fiber with adequate hydration
• Consider osmotic laxatives (polyethylene glycol, lactulose, magnesium salts) 2, 6
• Add stimulant laxatives (bisacodyl, senna) if osmotic agents insufficient 2

Address underlying Sjögren's disease activity: Since gastrointestinal symptoms correlate with overall disease activity 1, optimizing systemic disease management with hydroxychloroquine or immunosuppressive therapy when indicated may provide indirect benefit 7.

Screen for coexisting conditions: Gastroparesis, small intestinal bacterial overgrowth, and other motility disorders may complicate the picture and require targeted evaluation 8.

Important Caveats

• Do not attribute symptoms to IBS until comprehensive investigation excludes organic causes, particularly in patients without pre-existing IBS 9
• Nocturnal symptoms and steatorrhea are never features of IBS and warrant thorough investigation 9
• Recent onset or worsening constipation in established Sjögren's patients may signal disease progression or development of complications including lymphoma, which occurs at increased risk in this population 4
• Medication review is essential, as many drugs used in Sjögren's management (anticholinergics, antidepressants) can worsen constipation 10

The recognition that gastrointestinal involvement, including constipation, is common in Sjögren's syndrome should prompt clinicians to actively screen for these symptoms and provide appropriate management, as they significantly impact quality of life 1, 11.